It has been a mixed year for Kymera Therapeutics, Inc. insiders: $172.5 million bought by one person and $479.3 million sold by 11, so more selling than buying overall.
The largest purchase came from BAKER FELIX (Director), about $158.1 million.
275 investment managers listed KYMR in their latest 13F filings (Q2 2026); more funds bought than sold. Zooming out by quarter: 3 quarters in a row of net selling by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Mainolfi Nello | CEO | Sell | 4,876 | $113.24 | $552K | SEC |
| Oct 1, 2026 | Mainolfi Nello | CEO | Sell | 7,601 | $114.43 | $870K | SEC |
| Oct 1, 2026 | Mainolfi Nello | CEO | Sell | 3,525 | $111.44 | $393K | SEC |
| Oct 1, 2026 | Mainolfi Nello | CEO | Sell | 5,506 | $112.42 | $619K | SEC |
| Oct 1, 2026 | Mainolfi Nello | CEO | Sell | 8,230 | $115.40 | $950K | SEC |
| Oct 1, 2026 | Mainolfi Nello | CEO | Sell | 262 | $116.12 | $30K | SEC |
| Sep 4, 2026 | Adams Brian | Executive Officer | Sell | 1,209 | $115.55 | $140K | SEC |
| Sep 4, 2026 | Adams Brian | Executive Officer | Sell | 3,025 | $116.81 | $353K | SEC |
| Sep 4, 2026 | Adams Brian | Executive Officer | Sell | 2,137 | $117.57 | $251K | SEC |
| Jul 7, 2026 | Mainolfi Nello | CEO | Sell | 50,000 | $119.00 | $6.0M | SEC |
| Jul 2, 2026 | Jacobs Bruce N. | CFO | Sell | 1,700 | $111.57 | $190K | SEC |
| Jul 2, 2026 | Jacobs Bruce N. | CFO | Sell | 6,153 | $116.99 | $720K | SEC |
| Jul 2, 2026 | Mainolfi Nello | CEO | Sell | 6,626 | $113.98 | $755K | SEC |
| Jul 2, 2026 | Mainolfi Nello | CEO | Sell | 44,050 | $115.69 | $5.1M | SEC |
| Jul 2, 2026 | Mainolfi Nello | CEO | Sell | 24,105 | $114.96 | $2.8M | SEC |
In the last 12 months Kymera Therapeutics, Inc. insiders made open-market purchases worth about $172.5 million and sales worth about $479.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in KYMR was filed on 2026-10-01.
275 investment managers reported holding KYMR in SEC Form 13F filings for Q2 2026.
No congressional trades in KYMR were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).